Avid Bioservices, Inc. (CDMO): Price and Financial Metrics
Avid Bioservices, Inc. (CDMO)
Today's Latest Price: $8.20 USD
Updated Oct 23 6:55pm
Add CDMO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
CDMO Stock Summary
- The price/operating cash flow metric for Avid Bioservices Inc is higher than 95.22% of stocks in our set with a positive cash flow.
- Of note is the ratio of Avid Bioservices Inc's sales and general administrative expense to its total operating expenses; 83.97% of US stocks have a lower such ratio.
- As for revenue growth, note that CDMO's revenue has grown 24.12% over the past 12 months; that beats the revenue growth of 81.94% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Avid Bioservices Inc are MC, ROLL, WNS, AAON, and USPH.
- Visit CDMO's SEC page to see the company's official filings. To visit the company's web site, go to avidbio.com.
CDMO Stock Price Chart Interactive Chart >
CDMO Price/Volume Stats
| Current price | $8.20 | 52-week high | $9.10 |
| Prev. close | $8.15 | 52-week low | $3.02 |
| Day low | $7.96 | Volume | 139,000 |
| Day high | $8.26 | Avg. volume | 390,380 |
| 50-day MA | $7.88 | Dividend yield | N/A |
| 200-day MA | $6.52 | Market Cap | 464.14M |
Avid Bioservices, Inc. (CDMO) Company Bio
Avid Bioservices, Inc., formerly Peregrine Pharmaceuticals, researches and develops monoclonal antibodies for the treatment of cancer in the United States. Its lead immunotherapy candidate includes bavituximab, a monoclonal antibody that targets and binds to phosphatidylserine. The company was founded in 1981 and is based in Tustin, California.
Loading social stream, please wait...